维生素D受体多态性及其对血钙正常的甲状旁腺功能亢进患者骨密度的影响。 - Suppr

Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

作者信息

Castrillón Jose Luis Perez, Díaz-Soto Gonzalo, Jauregui Olatz Izaola, Romero Enrique, de Luis Román Daniel

机构信息

Internal Medicine Service, Hospital Rio Hortega, IEN-University of Valladolid, Calle Dulzaina 2, 47012, Valladolid, Spain.

Center of Investigation of Endocrinology and Nutrition Medicine School, IEN-University of Valladolid, Valladolid, Spain.

出版信息

Endocrine. 2015 Dec;50(3):816-8. doi: 10.1007/s12020-015-0611-0. Epub 2015 Apr 21.

DOI:10.1007/s12020-015-0611-0

PMID:25896554

Abstract

摘要

相似文献

Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

Endocrine. 2015 Dec;50(3):816-8. doi: 10.1007/s12020-015-0611-0. Epub 2015 Apr 21.

Clinical Expression of Calcium Sensing Receptor Polymorphism (A986S) in Normocalcemic and Asymptomatic Hyperparathyroidism.

Horm Metab Res. 2016 Mar;48(3):163-168. doi: 10.1055/s-0035-1559723. Epub 2015 Sep 2.

Vitamin D receptor polymorphisms as a determinant of bone mass and PTH secretion: from facts to controversies.

Nephrol Dial Transplant. 1999 May;14(5):1066-8. doi: 10.1093/ndt/14.5.1066.

Of bone and genes: vitamin D receptor polymorphism and primary hyperparathyroidism.

Eur J Endocrinol. 1996 Jun;134(6):685-6. doi: 10.1530/eje.0.1340685.

The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels.

J Clin Endocrinol Metab. 1999 May;84(5):1690-4. doi: 10.1210/jcem.84.5.5707.

Influence of Bsml vitamin D receptor gene polymorphism on the response to a single bolus of calcitrol in hemodialysis patients.

Clin Nephrol. 2001 Aug;56(2):111-6.

Vitamin D receptor gene polymorphisms and bone mineral density in patients on hemodialysis.

Nephron. 2000 Apr;84(4):381-2. doi: 10.1159/000045617.

The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.

J Bone Miner Res. 2002 Oct;17(10):1768-73. doi: 10.1359/jbmr.2002.17.10.1768.

Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.

J Clin Endocrinol Metab. 1997 Jun;82(6):1772-5. doi: 10.1210/jcem.82.6.4012.

Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.

Clin Rheumatol. 2016 Nov;35(11):2789-2795. doi: 10.1007/s10067-016-3237-6. Epub 2016 Mar 31.

引用本文的文献

Bone Turnover Markers: Basic Biology to Clinical Applications.

Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031.

Impact of vitamin D receptor polymorphisms in centenarians.

Endocrine. 2016 Aug;53(2):558-64. doi: 10.1007/s12020-016-0908-7. Epub 2016 Mar 8.

本文引用的文献

Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention.

Hormones (Athens). 2012 Oct-Dec;11(4):390-6. doi: 10.14310/horm.2002.1370.

1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.

PLoS One. 2013;8(2):e56019. doi: 10.1371/journal.pone.0056019. Epub 2013 Feb 13.

Normocalcemic primary hyperparathyroidism.

J Clin Densitom. 2013 Jan-Mar;16(1):33-9. doi: 10.1016/j.jocd.2012.12.001.

Bone turnover markers in primary hyperparathyroidism.

J Clin Densitom. 2013 Jan-Mar;16(1):22-7. doi: 10.1016/j.jocd.2012.11.004.

Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.

Endocrine. 2013 Aug;44(1):255-63. doi: 10.1007/s12020-013-9881-6. Epub 2013 Jan 20.

Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women.

Endocrine. 2012 Dec;42(3):764-6. doi: 10.1007/s12020-012-9694-z.

"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".

BMC Med Genet. 2011 Dec 20;12:168. doi: 10.1186/1471-2350-12-168.

Catabolic and anabolic actions of parathyroid hormone on the skeleton.

J Endocrinol Invest. 2011 Nov;34(10):801-10. doi: 10.3275/7925. Epub 2011 Sep 23.

Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study.

Calcif Tissue Int. 2011 Mar;88(3):238-45. doi: 10.1007/s00223-010-9454-0. Epub 2010 Dec 23.

The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.

J Clin Endocrinol Metab. 2008 Mar;93(3):967-73. doi: 10.1210/jc.2007-1645. Epub 2007 Dec 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

作者信息

Castrillón Jose Luis Perez, Díaz-Soto Gonzalo, Jauregui Olatz Izaola, Romero Enrique, de Luis Román Daniel

机构信息

Internal Medicine Service, Hospital Rio Hortega, IEN-University of Valladolid, Calle Dulzaina 2, 47012, Valladolid, Spain.

Center of Investigation of Endocrinology and Nutrition Medicine School, IEN-University of Valladolid, Valladolid, Spain.

出版信息

Endocrine. 2015 Dec;50(3):816-8. doi: 10.1007/s12020-015-0611-0. Epub 2015 Apr 21.

DOI:10.1007/s12020-015-0611-0

PMID:25896554

Abstract

摘要

相似文献

Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

Endocrine. 2015 Dec;50(3):816-8. doi: 10.1007/s12020-015-0611-0. Epub 2015 Apr 21.

Clinical Expression of Calcium Sensing Receptor Polymorphism (A986S) in Normocalcemic and Asymptomatic Hyperparathyroidism.

Horm Metab Res. 2016 Mar;48(3):163-168. doi: 10.1055/s-0035-1559723. Epub 2015 Sep 2.

Vitamin D receptor polymorphisms as a determinant of bone mass and PTH secretion: from facts to controversies.

Nephrol Dial Transplant. 1999 May;14(5):1066-8. doi: 10.1093/ndt/14.5.1066.

Of bone and genes: vitamin D receptor polymorphism and primary hyperparathyroidism.

Eur J Endocrinol. 1996 Jun;134(6):685-6. doi: 10.1530/eje.0.1340685.

The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels.

J Clin Endocrinol Metab. 1999 May;84(5):1690-4. doi: 10.1210/jcem.84.5.5707.

Influence of Bsml vitamin D receptor gene polymorphism on the response to a single bolus of calcitrol in hemodialysis patients.

Clin Nephrol. 2001 Aug;56(2):111-6.

Vitamin D receptor gene polymorphisms and bone mineral density in patients on hemodialysis.

Nephron. 2000 Apr;84(4):381-2. doi: 10.1159/000045617.

The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.

J Bone Miner Res. 2002 Oct;17(10):1768-73. doi: 10.1359/jbmr.2002.17.10.1768.

Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.

J Clin Endocrinol Metab. 1997 Jun;82(6):1772-5. doi: 10.1210/jcem.82.6.4012.

Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.

Clin Rheumatol. 2016 Nov;35(11):2789-2795. doi: 10.1007/s10067-016-3237-6. Epub 2016 Mar 31.

引用本文的文献

Bone Turnover Markers: Basic Biology to Clinical Applications.

Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031.

Impact of vitamin D receptor polymorphisms in centenarians.

Endocrine. 2016 Aug;53(2):558-64. doi: 10.1007/s12020-016-0908-7. Epub 2016 Mar 8.

本文引用的文献

Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention.

Hormones (Athens). 2012 Oct-Dec;11(4):390-6. doi: 10.14310/horm.2002.1370.

1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.

PLoS One. 2013;8(2):e56019. doi: 10.1371/journal.pone.0056019. Epub 2013 Feb 13.

Normocalcemic primary hyperparathyroidism.

J Clin Densitom. 2013 Jan-Mar;16(1):33-9. doi: 10.1016/j.jocd.2012.12.001.

Bone turnover markers in primary hyperparathyroidism.

J Clin Densitom. 2013 Jan-Mar;16(1):22-7. doi: 10.1016/j.jocd.2012.11.004.

Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.

Endocrine. 2013 Aug;44(1):255-63. doi: 10.1007/s12020-013-9881-6. Epub 2013 Jan 20.

Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women.

Endocrine. 2012 Dec;42(3):764-6. doi: 10.1007/s12020-012-9694-z.

"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".

BMC Med Genet. 2011 Dec 20;12:168. doi: 10.1186/1471-2350-12-168.

Catabolic and anabolic actions of parathyroid hormone on the skeleton.

J Endocrinol Invest. 2011 Nov;34(10):801-10. doi: 10.3275/7925. Epub 2011 Sep 23.

Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study.

Calcif Tissue Int. 2011 Mar;88(3):238-45. doi: 10.1007/s00223-010-9454-0. Epub 2010 Dec 23.

The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.

J Clin Endocrinol Metab. 2008 Mar;93(3):967-73. doi: 10.1210/jc.2007-1645. Epub 2007 Dec 11.

Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Polymorphisms of the vitamin D receptor and their effect on bone mass density in patients with normocalcemic hyperparathyroidism.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献